In PNAS this week: genomic responses in drug-treated malaria parasites, characterization of marine sponge's bacterial symbionts, and more.
A study led by Johns Hopkins describes a method for automating slow, inaccurate manual chart review when searching for signs of misdiagnosis.
A family of tail-less, double-stranded DNA viruses with potent bacteria killing abilities turned up in Vibrionaceae family bacteria from marine samples.
Researchers tie a deletion to longevity, but only among men, according to the New York Times.
The company was founded earlier this year based on an improved method for multiple displacement amplification and a single-cell-variant caller.
In Nature this week: genotypes linked to hip osteoarthritis, and more.
The researchers reported that their assay could detect women with defective double-stranded break repair pathways even when sequencing could not.
The researchers will look for disease-causing variants in individuals with congenital heart disease who also have a chromosomal deletion syndrome.
Translational scientist Jacqueline Achkar of Albert Einstein Medical College will lead several collaborations to build a point-of-care diagnostic platform.
Researchers sequenced the APOE gene in over 900 individuals, finding supporting evidence for the APOE2 allele's role in longevity and lower levels of lipids.
The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.
Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.
Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.
In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.